These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 15725261)

  • 1. Recent advances in rheumatology: biological agents for the treatment of rheumatoid arthritis, the progression of psoriatic arthritis, autoantibodies in systemic lupus erythematosus.
    Finucane KA; Archer CB
    Clin Exp Dermatol; 2005 Mar; 30(2):201-4. PubMed ID: 15725261
    [No Abstract]   [Full Text] [Related]  

  • 2. Biologic therapy for early rheumatoid arthritis: the latest evidence.
    Castro-Rueda H; Kavanaugh A
    Curr Opin Rheumatol; 2008 May; 20(3):314-9. PubMed ID: 18388524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of rheumatoid arthritis.
    Handa R
    Natl Med J India; 2004; 17(3):143-51. PubMed ID: 15253402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innovative treatment strategies for patients with rheumatoid arthritis.
    van der Kooij SM; Allaart CF; Dijkmans BA; Breedveld FC
    Curr Opin Rheumatol; 2008 May; 20(3):287-94. PubMed ID: 18388520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies in biological agent naive patients with psoriatic arthritis.
    Johnson SR; Schentag CT; Gladman DD
    Ann Rheum Dis; 2005 May; 64(5):770-2. PubMed ID: 15834057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psoriatic arthritis: current concepts on pathogenesis-oriented therapeutic options.
    Turkiewicz AM; Moreland LW
    Arthritis Rheum; 2007 Apr; 56(4):1051-66. PubMed ID: 17393414
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis treated with anti-tumour necrosis factor agents.
    Russell AS; Maksymowych WP; de Silva M
    Ann Rheum Dis; 2005 Dec; 64(12):1807. PubMed ID: 16284357
    [No Abstract]   [Full Text] [Related]  

  • 8. The NICE reappraisal of biologics in 2005: what rheumatologists need to know.
    Bansback NJ; Young A; Brennan A
    Rheumatology (Oxford); 2005 Jan; 44(1):3-4. PubMed ID: 15328422
    [No Abstract]   [Full Text] [Related]  

  • 9. [Biopharmaceuticals in the treatment of rheumatoid arthritis].
    Baslund B; Bendtzen K
    Ugeskr Laeger; 2008 Jun; 170(24):2108-10. PubMed ID: 18572481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-CD20 monoclonal antibody in rheumatoid arthritis and systemic lupus erythematosus.
    Goldblatt F; Isenberg DA
    Handb Exp Pharmacol; 2008; (181):163-81. PubMed ID: 18071946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of systemic lupus erythematosus with focal proliferative lupus nephritis during anti-TNF-alpha therapy for psoriatic arthritis].
    Haake H; Köneke J; Amann K; vom Dahl J; Janssen U
    Med Klin (Munich); 2007 Oct; 102(10):852-7. PubMed ID: 17928969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etanercept-associated SLE with lupus nephritis.
    Neradová A; Stam F; van den Berg JG; Bax WA
    Lupus; 2009 Jun; 18(7):667-8. PubMed ID: 19433471
    [No Abstract]   [Full Text] [Related]  

  • 13. Anti-tumor necrosis factor agents are mostly used in patients with established rheumatoid arthritis compared to early disease -- a reflection of adequate clinical practice.
    Haraoui B
    J Rheumatol; 2009 Aug; 36(8):1561-2. PubMed ID: 19671804
    [No Abstract]   [Full Text] [Related]  

  • 14. Recent therapeutic advances in the treatment of rheumatoid arthritis.
    Jonas BL
    N C Med J; 2007; 68(6):425-6. PubMed ID: 18236860
    [No Abstract]   [Full Text] [Related]  

  • 15. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
    Hyrich KL; Watson KD; Silman AJ; Symmons DP;
    Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biological treatment of rare inflammatory rheumatic diseases].
    Baslund B
    Ugeskr Laeger; 2008 Jun; 170(24):2150-2. PubMed ID: 18565301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intra-articular infliximab in patients with rheumatoid arthritis and psoriatic arthritis with monoarthritis resistant to local glucocorticoids. Clinical efficacy extended to patients on systemic anti-tumour necrosis factor alpha.
    Conti F; Ceccarelli F; Priori R; Iagnocco A; Signore A; Valesini G
    Ann Rheum Dis; 2008 Dec; 67(12):1787-90. PubMed ID: 19005158
    [No Abstract]   [Full Text] [Related]  

  • 18. Anti-TNF-induced lupus.
    Williams EL; Gadola S; Edwards CJ
    Rheumatology (Oxford); 2009 Jul; 48(7):716-20. PubMed ID: 19416947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do all drugs and treatments for rheumatoid arthritis have the same efficacy?
    Weisman MH
    Nat Clin Pract Rheumatol; 2008 Jun; 4(6):298-9. PubMed ID: 18431369
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists.
    Fernández-Nebro A; Tomero E; Ortiz-Santamaría V; Castro MC; Olivé A; de Haro M; Portales RG; González-Mari MV; Laffón A; García-Vicuña R
    Am J Med; 2005 May; 118(5):552-6. PubMed ID: 15866260
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.